Bruker Completes Asset Acquisition of NanoString Business
Adds Highly Complementary Business in Gene Expression Profiling and Spatial Transcriptomics for Discovery and Translational Research ...
Stay updated with breaking news from Markr Munch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Adds Highly Complementary Business in Gene Expression Profiling and Spatial Transcriptomics for Discovery and Translational Research ...
NanoString is an Established Leader and Valuable Innovator in Gene Expression Profiling and Spatial Transcriptomics for Scientific and Clinical Research in Healthcare ...
03.10.2023 - Bruker Corporation (Nasdaq: BRKR) today announced that it has completed the acquisition of PhenomeX, a leading provider of single-cell biology research tools, for $108 million in cash. Bruker announced the agreement to acquire PhenomeX on August 17, ... Seite 1
Amongst a challenging funding landscape, PhenomeX emerges by clinching an irresistible deal With Bruker. Here's more on the transaction.
Acquisition initiates Bruker’s entry into functional single-cell biology research solutions ...